A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis
- DOI
- 10.1186/s13054-024-05232-3
- Published
- 2025-01-13
- Container
- Critical Care
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13054-024-05232-3,
title = {A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis},
author = {Heekuk Park and Elissa Lynch and Alice Tillman and Kristen Lewis and Zhezhen Jin and Anne-Catrin Uhlemann and Julian A. Abrams and Daniel E. Freedberg},
year = {2025},
journal = {Critical Care},
doi = {10.1186/s13054-024-05232-3},
url = {https://doi.org/10.1186/s13054-024-05232-3}
}RIS
TY - JOUR TI - A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis AU - Heekuk Park AU - Elissa Lynch AU - Alice Tillman AU - Kristen Lewis AU - Zhezhen Jin AU - Anne-Catrin Uhlemann AU - Julian A. Abrams AU - Daniel E. Freedberg PY - 2025 JO - Critical Care DO - 10.1186/s13054-024-05232-3 UR - https://doi.org/10.1186/s13054-024-05232-3 ER -
APA
Park, H., Lynch, E., Tillman, A., Lewis, K., Jin, Z., Uhlemann, A., Abrams, J. A., & Freedberg, D. E. (2025). A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis. Critical Care. https://doi.org/10.1186/s13054-024-05232-3
Source records
- crossref · retrieved 2026-09-27T02:45:41.890Z